Switzerland · 
Who invested in Oculis?
Oculis's investors include Novartis, Bay City Capital and Pivotal bio.
20172018
$20MRound$16MSeries BSwitzerland · Series B startup
Who invested in Oculis
2 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$36Mraised across 2 rounds since 2017, from 2 sources
$20MRound$16MSeries B
- Latest round
- Series B, $16MJan 2018
- Biggest round
- $20MRound · Jan 2017
- Investors
- 3
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Round, $20M Jan 2017
- Biggest round
- $20M Round · Jan 2017
- Between rounds
- 12 months from the last two
The rounds
- Jan 2018
- Jan 2017
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
This firm lists Oculis as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Oculis
How much has Oculis raised?
Oculis has raised $36M across 2 rounds since 2017.
When did Oculis last raise?
Oculis's most recent round was a Series B of $16M in Jan 2018.
What was Oculis's biggest round?
Oculis's largest round on record is $20M (Undisclosed round), in Jan 2017.
Who backed Oculis first?
Oculis's first round on record, in Jan 2017, was backed by Novartis, Bay City Capital and Pivotal bio.
What stage is Oculis at?
Oculis's latest named round is a Series B, in Jan 2018.
Where is Oculis based?
Oculis is based in Switzerland.
Companies like Oculis
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.